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Abstract
Vibrio vulnificus (Vv) is a pathogenic bacterium that can cause life-threatening infections in
humans. Most fatal cases are due to septic shock that results from dysregulation of cytokines,
particularly TNFα, which plays a critical role in the outcome of Vv infection. The goal of this
study was to investigate the Toll-like receptor (TLR)-mediated TNFα response to four Vv biotype
1 strains using mice deficient for TLR2, TLR4 and TLR2/TLR4. Ex vivo assays were performed
with blood, splenocytes, and Kupffer cells (KC) from wild type (WT) and TLR knockout (KO)
mice using formalin-inactivated Vv (f-Vv) as stimulant. All f-Vv biotype 1 strains elicited strong
TNFα production by WT mouse blood and cells, which was TLR2- and TLR4-dependent.
OxPAPC, an inhibitor of TLR2 and TLR4 signaling, effectively blunted the TLR-mediated TNFα
response to f-Vv. Furthermore, TLR2 KO and TLR2/TLR4 KO mice were more resistant to lethal
infection with Vv ATCC 27562 than WT mice, perhaps due to attenuation of the TNFα response.
These data suggest that it may be possible to devise strategies to specifically target the harmful
TLR-mediated TNFα response as an adjunct to antibiotic treatment of severe Vv infection.
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Vibrio vulnificus (Vv) is a Gram-negative, motile bacterium that is ubiquitous in warm
coastal environments (Jones & Oliver, 2009; Horseman & Surani, 2011). Infection, caused
mainly by Vv biotype 1 strains, manifests as gastroenteritis, primary septicemia, or wound
infection. Even with antibiotic treatment, mortality rates can exceed 50% for primary
septicemia and 25% for wound infection (Jones & Oliver, 2009; Horseman & Surani, 2011).
Fatalities are due to septic shock that results from dysregulation of cytokines, particularly
TNFα, presumably owing to recognition of Vv agonists by Toll-like receptors (TLRs) (Espat
et al., 1996; Shin et al., 2002; Powell et al., 2003; Toma et al., 2010). Previous studies
showed that recognition of recombinant-produced Vv lipoprotein (IlpA) and flagellar
filament protein (FlaB) and isolated capsular polysaccharide by TLR1/TLR2, TLR5, and
TLR2, respectively, resulted in the production of inflammatory cytokines (Lee et al., 2006;
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Goo et al., 2007; Lee et al., 2010; Lee et al., 2011). Additionally, Stamm (2010) reported
that TLR4 played a role in TNFα production by mouse blood and splenocytes following
stimulation with formalin-inactivated Vv (f-Vv), and that TLR4 knockout (KO) mice, but not
MyD88 KO mice, were more resistant to lethal Vv infection than wild-type (WT) mice.
Because TLRs are potential targets for attenuating the harmful cytokine response (Boyd,
2012), the goal of this study was to investigate the TLR-mediated TNFα response to four Vv
biotype 1strains using mice deficient for TLR2, TLR4, and TLR2/TLR4.
WT C57BL/6 and TLR2 KO mice were purchased from Jackson Laboratory (Bar Harbor,
ME). TLR4 KO and TLR2/TLR4 KO mice were provided by B. Vilen and M. Heise,
respectively (University of North Carolina, Chapel Hill, NC). All TLR KO mice had been
backcrossed to WT C57BL/6 mice for at least eight generations. Experiments used 10–13
week old male mice. Animal procedures were approved by the UNC-CH Institutional
Animal Care and Use Committee.
Vv ATCC 27562 (type strain) was purchased from Remel (Lake Charles, LA). C7184 and
YJ016 were provided by J. Oliver (UNC, Charlotte, NC) and MO6-24/O by A. Wright
(University of Florida, Gainesville, FL). Vv strains were grown in Heart Infusion (HI) broth
as described previously (Stamm, 2010) and quantified with a Petroff-Hausser counting
chamber. Vv were formalin-inactivated to prevent overgrowth during ex vivo assays (Stamm,
2010).
Ex vivo assays were performed with duplicate samples of heparinized mouse blood (50 μl/
tube) and with splenocytes (5 × 105 cells/well) in 400μl RPMI 1640 medium without
stimulant or with stimulant (i.e., 2.5 × 106 f-Vv or control TLR agonists) as described
previously (Stamm, 2010). Splenocytes were obtained by mechanical disruption of spleens
followed by lysis of red blood cells and resuspension of the washed splenocytes in RPMI
1640 medium with 5% heat-inactivated fetal bovine serum (HI-FBS). Assays with blood and
splenocytes were performed three times. Liver macrophages (Kupffer cells, KC) were
isolated with OptiPrep (Sigma-Aldrich, St. Louis, MO) (Froh et al. 2002). KC were plated at
4 × 105 cells/well, washed gently after adhering for 2h, and incubated in RPMI 1640
medium with 5% HI-FBS in 5% CO2 at 37°C for 24h before replacement of medium with
400μl fresh medium without or with stimulant. Assays with KC were performed two times.
Pam3CSK4, a synthetic mimetic of bacterial lipoprotein (InVivoGen, San Diego, CA) (50
ng) and purified Escherichia coli lipopolysaccharide (Ec LPS) (Sigma-Aldrich) (40 ng) were
used as control TLR2 and TLR4 agonists, respectively. After a 24h incubation period, cell-
free supernatants were collected and stored at −80°C until tested in duplicate by ELISA for
TNFα (R & D Systems, Inc., Minneapolis, MN). Statistical analysis was performed with the
unpaired, two-tailed t test for comparison of two groups or ANOVA for comparison of three
or more groups followed by the Bonferroni post test or the post test for linear trend (Prism
5c, GraphPad Software, Inc., San Diego, CA). P <0.05 was considered significant.
For Vv infection, groups of eight to ten WT, TLR2 KO, and TLR2/TLR4 KO mice were
infected intraperitoneally with 5–7 × 107 Vv ATCC 27562 that had been grown at 33C in HI
broth, washed once in phosphate buffered saline (PBS) and suspended in PBS (Stamm,
2010). WT and TLR2 KO mice were tested concurrently in three independent experiments.
Stamm and Drapp Page 2






















TLR2/TLR4 KO mice were included in two of the experiments. Survival was monitored for
48h post infection. Mice that became irreversibly moribund based on established criteria
(i.e., reduced mobility, hunched posture, poor grooming, rapid breathing) were euthanized
and counted as nonsurvivors. Statistical significance of the combined data was evaluated
with Fisher’s exact test (Prism 5c).
For this study, ex vivo assays were used to investigate the role of TLR2 and TLR4 in the
TNFα response of mice to four Vv biotype 1 strains that were isolated previously from
septicemic patients (Rouche et al., 2005; Chatzidaki-Livanis et al., 2006; Thiaville et al.,
2011). Aliquots of blood from WT, TLR2 KO, TLR4 KO, and TLR2/TLR4 KO mice were
incubated in medium without stimulant or in medium with f-Vv or control TLR agonists. A
high level of TNFα was detected in supernatants from WT blood stimulated with each of the
f-Vv strains (P <0.01) (Fig. 1A) or with the control TLR agonists (P <0.01) (Supplemental,
Fig. 1a) compared with supernatants from WT blood without stimulant in which TNFα was
undetectable (i.e., below the 31 pg ml−1 detection limit) (data not shown). Compared with
WT supernatants, the TLR2 KO and TLR4 KO supernatants contained less TNFα after
stimulation with each of the f-Vv strains (P <0.01) (Fig. 1A) or with the control TLR
agonists, PAM3CSK4 and Ec LPS, respectively (P <0.01) (Supplemental, Fig. 1a). The
TNFα level of supernatants from TLR4 KO blood stimulated with the f-Vv strains was
higher than that of supernatants from comparably stimulated TLR2 KO blood (P <0.01).
Interestingly, variability was observed in the TNFα level among supernatants from WT
blood stimulated with the four f-Vv strains (P <0.01) or among supernatants from TLR2 KO
or TLR4 KO blood stimulated with these strains (P <0.01) suggesting that the expression
and/or structure of Vv TLR2 (i.e., capsule, lipoproteins) and TLR4 (LPS) agonists may differ
among the strains. The TNFα level of supernatants from TLR2/TLR4 KO blood stimulated
with the f-Vv strains was typically low or undetectable compared to that of supernatants
from comparably stimulated WT, TLR2 KO or TLR4 KO blood (P <0.01) (Fig. 1A). These
results indicated that virtually all of the TNFα response of WT blood to the f-Vv strains was
mediated by TLR2 and TLR4 signaling. Support for these findings was obtained when WT
blood was incubated with f-Vv ATCC 27562 in the presence of OxPAPC (InVivoGen).
OxPAPC is a mixture of oxidized phospholipids, which blocks TLR2 and TLR4 signaling
by competing with accessory proteins (i.e., CD14, LBP, and MD2) that interact with TLR2
and TLR4 agonists (i.e., capsule, lipoproteins, LPS) (Erridge et al., 2008; Zughaier, 2011).
Consistent with the TLR KO data, the TNFα response of WT blood to f-Vv (P <0.01) and to
the control TLR agonists (P <0.01) was strongly inhibited by the addition of OxPAPC (Fig.
1B).
To evaluate further the role of TLR2 and TLR4 in the TNFα response to the f-Vv strains, ex
vivo assays were performed with WT and TLR KO splenocytes. Results were similar to
those observed with blood. A high level of TNFα was detected in supernatants of WT
splenocytes stimulated with the four f-Vv strains (P <0.01) (Fig. 1C) or with the control TLR
agonists (P <0.01) (Supplemental, Fig. 1b) compared to supernatants from WT splenocytes
without stimulant in which TNFα was undetectable (data not shown). Supernatants from
TLR2 KO and TLR4 KO splenocytes stimulated with the f-Vv strains (P <0.01) or with the
control TLR agonists (P <0.01) contained less TNFα than those from corresponding WT
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splenocytes stimulated with the f-Vv strains (Fig. 1C) or with the control TLR agonists
(Supplemental Fig. 1b). Comparison of the TNFα level of supernatants from TLR4 KO and
TLR2 KO splenocytes stimulated with the f-Vv strains showed that the TNFα level was
different for MO6-24/O and C7184 (P <0.01), but not for ATCC 27562 or YJ016 (P >0.54).
Variability was observed in the TNFα level among supernatants from WT splenocytes
stimulated with the four f-Vv strains (P <0.03) or among supernatants from TLR2 KO or
TLR4 KO splenocytes stimulated with these strains (P <0.01). The TNFα level of
supernatants from TLR2/TLR4 KO splenocytes stimulated with the f-Vv strains was very
low or undetectable compared with that of supernatants from comparably stimulated WT,
TLR2 KO or TLR4 KO splenocytes (P <0.01) (Fig. 1C).
Because KC are a major source of TNFα when activated by TLR agonists of blood and gut
pathogens (Bilzer et al., 2006; Wu et al., 2009), ex vivo assays were also performed with
WT and TLR KO KC. A high level of TNFα was detected in supernatants from WT KC
stimulated with the four f-Vv strains (P <0.01) (Fig. 1D) or with the control TLR agonists (P
<0.01) (Supplemental, Fig. 1c) compared to supernatants from WT KC without stimulant in
which TNFα was undetectable (data not shown). As observed for blood and splenocytes,
supernatants from TLR2 KO and TLR4 KO KC (P <0.01) stimulated with the f-Vv strains or
with the control TLR agonists (P <0.01) contained less TNFα than supernatants from
corresponding WT KC stimulated with the f-Vv strains (Fig. 1D) or with the control TLR
agonists (Supplemental Fig. 1c). The TNFα level of supernatants from TLR2/TLR4 KO KC
stimulated with the f-Vv strains was very low or undetectable compared with that of
supernatants from WT, TLR2 KO or TLR4 KO KC (P <0.01) (Fig. 1D). Although
variability was not observed in the TNFα response among supernatants from WT KC (P
=0.23) or among supernatants from TLR4 KO KC (P > 0.24) stimulated with the four f-Vv
strains, variability was observed in the TNFα response among supernatants from TLR2 KO
KC (P <0.01) stimulated with these strains (Fig. 1D). In contrast to the TNFα level of
supernatants from TLR4 KO blood stimulated with the f-Vv strains, which was consistently
higher than that from comparably stimulated TLR2 KO blood (P <0.01), the TNFα level of
supernatants from TLR4 KO KC stimulated with the f-Vv strains was consistently lower
than that from comparably stimulated TLR2 KO KC (P <0.01). These results suggest that
the TNFα response of KC to f-Vv was largely mediated by TLR4. Information concerning
mouse KC TLR expression is limited. However, because KC are a more homogenous cell
population than blood, variation in TLR expression levels may account for the different
trends observed in the TLR2- and TLR4-mediated TNFα response of KC and blood.
Stamm (2010) reported previously that TLR4- or TNFα-deficiency protected against lethal
infection with Vv ATCC 27562 in a mouse sepsis model. Because our ex vivo assays
showed that production of TNFα following stimulation with f-Vv was dependent upon TLR2
and TLR4, we examined the effect of TLR2 KO and TLR2/TLR4 KO on the susceptibility
of mice to lethal infection with Vv ATCC 27562. There was no difference in survival
between the TLR2 KO (88.5% survival) and TLR2/TLR4 KO mice (78.9% survival) (P
=0.43). However, these TLR KO mice were more resistant than WT mice (31% survival) to
lethal infection, indicating that a deficiency of TLR2 or TLR2/TLR4 (P <0.01) is protective.
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In summary, ex vivo assays were used to examine the TLR-mediated TNFα response of
mouse blood, splenocytes, and KC to four Vv biotype 1 strains. All f-Vv strains elicited
strong TNFα production by WT mouse blood and cells, which was TLR2- and TLR4-
dependent. Furthermore, TLR2 KO and TLR2/TLR4 KO mice were more resistant to lethal
infection with Vv than WT mice, perhaps due to attenuation of the TNFα response. These
data suggest that it may be possible to devise strategies to selectively target the harmful
TLR-mediated TNFα response. Spiller et al. (2008) showed that blockade of TLR2 and
TLR4 signaling with monoclonal antibodies, at the initiation of antibiotic therapy, is feasible
for treatment of experimental Gram-negative bacterial infections. Thus, we propose that
OxPAPC, which inhibited the TLR2- and TLR4-mediated TNFα response to f-Vv, warrants
investigation in the mouse model of Vv sepsis as an adjunct to antibiotic therapy.
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TNFα response of mouse blood and cells to stimulation with formalin-inactivated Vibrio
vulnificus (f-Vv) biotype 1 strains is mediated by TLR2 and TLR4. Ex vivo assays were
performed with blood or isolated cells pooled from two mice per each genotype. Duplicate
samples of wild-type (WT), TLR4 (T4) knockout (KO), TLR2 (T2) KO, and TLR2/TLR4
(T2/T4) KO blood (A), splenocytes (C), or Kupffer cells (KC) (D) were incubated in
duplicate without stimulant or with 2.5 × 106 f-Vv strains (ATCC 27562, MO6/24-O,
C7184, and YJ016) for 24h. Duplicate samples of WT blood (B) were incubated in duplicate
with 2.5 × 106 f-Vv ATCC 27562, Ec LPS (40 ng) or PAM3CSK4 (50 ng) with (+) or
without (−) OxPAPC (15 μg) for 24h. Duplicate supernatants were collected, pooled, and
tested in duplicate for TNFα by ELISA. Values are the mean (± SEM). Results are
representative of three independent experiments (A and C) or two independent experiments
(B and D). The TNFα level of supernatants from all WT and TLR KO samples incubated
without stimulant was below the assay detection limit (31 pg ml−1) and is not shown. **
Different compared with WT samples with the same stimulus (P <0.01) (A, C, D). **
Different compared with WT samples without OxPAPC (P <0.01) (B).
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